Paul M. Bisaro — Director at Allergan

Mr. Paul M. Bisaro serves as an Executive Chairman of Actavis Specialty Pharmaceuticals Co. and Actavis Pharma Company. Mr. Bisaro has been Chief Executive Officer and President of Impax Laboratories, Inc. since March 27, 2017. He serves as the Executive Chairman of Allergan Pharma Co. He served as the Chief Executive Officer, President, Chairman and Director at Actavis Limited since October 2013. He served as President and Chief Operating Officer of Barr Laboratories, Inc. He served as Chief Executive Officer and President of Allergan plc from September 4, 2007 to July 2014 and its Chairman of the Board from October 2013 to July 2014. He served as the President and Chief Operating Officer of Teva Branded Pharmaceutical Products R&D, Inc. from December 1999 to August 2007. He joined the Barr Pharmaceuticals Inc. in 1992 and served as its General Counsel from 1992 to 1999 and served in various additional capacities including Senior Vice President, Strategic Business Development from 1997 to 1999. He served as President and Chief Operating Officer of Teva Women's Health, Inc. until August 2, 2007. Mr. Bisaro has more than 20 years of experience in the healthcare industry. He served as the President and Chief Operating Officer of Barr Pharmaceuticals, Inc., from 1999 to 2007. He served as the President of Duramed and New BLI, both the subsidiaries of Barr Pharmaceuticals, Inc. He served as the Chief Operating Officer of New BLI. Prior to joining Barr, he was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds from 1989 to 1992. He also served as a Senior Consultant with Arthur Andersen & Co. He served as Member of Management Board at PLIVA Pharmaceuticals, Inc since November 2, 2006 and PLIVA-Lachema a.s. Mr. Bisaro served as an Executive Chairman of Allergan plc (formerly known as Actavis plc) from July 1, 2014 to October 26, 2016 and its Executive Director from September 4, 2007 until December 30, 2016. He served as the Chairman of Generic Pharmaceutical Association since 2010 and 2011 and served as its Vice Chairman. He serves as Director of Association for Accessible Medicines (a/ka/ Generic Pharmaceutical Association). He has been Director of Impax Laboratories, Inc. since March 27, 2017. He has been an Independent Director of Zoetis Inc. since May 01, 2015. He has been Director of Allergan plc (formerly known as Actavis plc) since September 4, 2007 and served as its Executive Director since September 4, 2007 until December 30, 2016. He serves as an Independent Director of Forsyth Capital Mortgage Corp. He served as an Independent Director of Zimmer Biomet Holdings, Inc. since December 16, 2013 until May 12, 2017. He served as a Director of Teva Branded Pharmaceutical Products R&D, Inc. from June 1998 to 2007. He served as Director of Barr Pharmaceuticals, Inc., from 1999 to 2007. Mr. Bisaro received his undergraduate degree in General Studies from the University of Michigan in 1983 and Juris Doctor from Catholic University of America in Washington DC in 1989.